Using vagus nerve stimulation with exercise to help chronic fatigue
Official title: Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue: Single-center, Controlled, Randomized, Blinded Study
Run by Centre Hospitalier Universitaire de Saint Etienne · NCT06170645 · Data updated 2026-11-12
This study is testing if using a special nerve stimulation along with a tailored exercise program can help people with chronic fatigue from fibromyalgia or long Covid feel better and recover faster.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 1 site (Saint-Etienne) |
| Status | Recruiting |
| Started | October 3, 2024 |
| Main results expected | February 2028 |
| Study ends | August 2028 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT06170645 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with a confirmed diagnosis of fibromyalgia or long Covid who experience persistent fatigue despite previous exercise rehabilitation.
✕Probably not a fit
Patients with severe heart conditions, recent strokes, or those who are pregnant or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of transcutaneous vagus nerve stimulation (tVNS) as a complementary therapy to an adapted physical activity (APA) program for patients suffering from chronic fatigue due to fibromyalgia or long Covid. Participants will engage in a 4-6 week APA program while receiving either active or sham tVNS to assess its impact on fatigue reduction and recovery. The goal is to enhance adherence to exercise protocols that are typically more effective when sustained over longer periods. By combining these two interventions, the study aims to improve overall patient outcomes in managing chronic fatigue.
Why it matters
Potential benefit: If successful, this approach could significantly reduce fatigue and improve recovery for patients with chronic fatigue syndrome.
How similar studies have gone: While the combination of tVNS and exercise is a novel approach, existing literature suggests that both interventions separately have shown promise in managing fatigue.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 years old * Signature of informed consent * Confirmed diagnosis of fibromyalgia or long Covid (ACR 2016 criteria and persistent symptoms lasting more than 6 months after a positive RT-PCR test, respectively) * Persistent fatigue after an exercise rehabilitation program (FSS score \> 36) * Physical inactivity, i.e. \<150 minutes per week of physical activity Exclusion Criteria: * Pre-existing atrial fibrillation, * Left ventricular ejection fraction \<40% * Severe heart failure * Recent stroke or myocardial infarction (\<6 months) * Unilateral or bilateral vagotomy * Pregnancy or breastfeeding
Where it's running
-
Centre Hospitalier de Saint-Etienne
Saint-Etienne, France Recruiting
Study contacts
- Principal investigator: David HUPIN, MD — Centre Hospitalier Universitaire de Saint Etienne
- Study coordinator: David HUPIN, MD
- Email: david.hupin@chu-st-etienne.fr
- Phone: (0)4 77 82 84 13
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric Oxygen Therapy for ME/CFS
This study tests whether hyperbaric oxygen therapy can help people with mild to moderate ME/CFS.
-
Remote Voice Analysis Tool to Help Diagnose and Monitor ME/CFS
A voice-based tool is tested to help diagnose and manage myalgic encephalomyelitis/chronic fatigue syndrome in people who have the condition.
-
Hydrogen water to reduce fatigue and improve function in ME/CFS
This project will try hydrogen water in adults with ME/CFS to see if it reduces fatigue and improves function and whether heart rate variability can predict who benefits.
-
Using Lumbrokinase to treat Long Covid, Lyme Disease, and Chronic Fatigue Syndrome
This study is testing if a treatment called Lumbrokinase can help adults with Long Covid, Lyme Disease, and Chronic Fatigue Syndrome feel better and improve their quality of life.
-
A study using wearable devices to manage Long COVID symptoms
This study is testing if using wearable devices can help people with Long COVID manage their symptoms and improve their quality of life.
-
Monitoring fatigue in breast cancer survivors
This study is testing how fatigue affects breast cancer survivors by using smart watches and apps to track their daily activities and energy levels after treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.